Hepatitis B virus X protein modulates apoptosis in primary rat hepatocytes by regulating both NF-κB and the mitochondrial permeability transition pore

Journal of Virology

Volumn 83, Issue 10, 2009, Pages 4718-4731

  Clippinger, Amy J ^a   Gearhart, Tricia L ^a   Bouchard, Michael J ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; CARRIER PROTEIN; MESSENGER RNA; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL IMMORTALIZATION; CELL STIMULATION; CELL TRANSFORMATION; CELL TYPE; CONTROLLED STUDY; EMBRYO; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CELL; MALE; MITOCHONDRIAL PERMEABILITY; MODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STIMULATION; VIRUS REPLICATION; ADENOVIRUS; ANIMAL; CELL CULTURE; GENETIC REASSORTMENT; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VIROLOGY;

HEPATITIS B VIRUS; RATTUS;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELLS, CULTURED; HEPATITIS B VIRUS; HEPATOCYTES; MALE; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; REASSORTANT VIRUSES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS REPLICATION;

EID: 65349104743     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02590-08     Document Type: Article

References (96)

1. Andrisani, O., and S. Barnabas. 1999. The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis. Int. J. Oncol. 15:373-379.
2. Beasley, R., C.-C. Lin, L.-Y. Hwang, and C.-S. Chien. 1981. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. Lancet ii:1129-1133.
3. Beg, A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782-784.
4. Bergametti, F., S. Prigent, B. Luber, A. Benoit, P. Tiollais, A. Sarasin, and C. Transy. 1999. The proapoptotic effect of hepatitis B virus HBx protein correlates with transactivation activity in stably transfected cell lines. Oncogene 18:2860-2871.
5. Berk, A. J. 2005. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24:7673-7685.
6. Bernardi, P., and A. Rasola. 2007. Calcium and cell death: the mitochondrial connection. Subcell. Biochem. 45:481-506.
7. Bingham, M. J., T. J. Ong, K. H. Summer, R. B. Middleton, and H. J. McArdle. 1998. Physiologic function of the Wilson disease gene product, ATP7B. Am. J. Clin. Nutr. 67:982S-987S.
8. Block, G., J. Locker, W. Bowen, B. Petersen, S. Katyal, S. Strom, T. Riley, T. Howard, and G. Michalopoulos. 1996. Population expression, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGFα in a chemically defined (HGM) medium. J. Cell Biol. 132:1133-1149. (Pubitemid 26105500)
9. Bouchard, M., L.-H. Wang, and R. Schneider. 2001. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 294:2376-2378.
10. Bouchard, M. J., R. J. Puro, L. Wang, and R. J. Schneider. 2003. Activation and inhibition of cellular calcium and tyrosine kinase signaling pathways identify targets of the HBx protein involved in hepatitis B virus replication. J. Virol. 77:7713-7719. (Pubitemid 36792767)
11. Bouchard, M. J., and R. J. Schneider. 2004. The enigmatic X gene of hepatitis B virus. J. Virol. 78:12725-12734. (Pubitemid 39507781)
12. Bour, E., L. Ward, G. Cornman, and H. Isom. 1996. Tumor necrosis factor-α-induced apoptosis in hepatocytes in long-term culture. Am. J. Pathol. 148:485-495. (Pubitemid 26056733)
13. Brockman, J., D. Scherer, T. McKinsey, S. Hall, X. Qi, W. Lee, and D. Ballard. 1995. Coupling of a signal response domain to IκB-α to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15:2809-2818.
14. Broekemeier, K., M. Dempsey, and D. Pfeiffer. 1989. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J. Biol. Chem. 264:7826-7830. (Pubitemid 19137258)
15. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
16. Catz, S. D., and J. L. Johnson. 2001. Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 20:7342-7351.
17. L. Mol. Cell. Biol. 20:2687-2695.
18. Chen, H., S. Kaneko, R. Girones, R. Anderson, W. Hornbuckle, B. Tennant, P. Cote, J. Gerin, R. Purcell, and R. Miller. 1993. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J. Virol. 67:1218-1226. (Pubitemid 23067624)
19. Chirillo, P., M. Falco, P. L. Puri, M. Artini, C. Balsano, M. Levrero, and G. Natoli. 1996. Hepatitis B virus pX activates NF-κB-dependent transcription through a Raf-independent pathway. J. Virol. 70:641-646. (Pubitemid 126508839)
20. Chirillo, P., S. Pagano, G. Natoli, P. Puri, V. Burgio, C. Balsano, and M. Levrero. 1997. The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc. Natl. Acad. Sci. USA 94:8162-8167.
21. Chisari, F. 2000. Viruses, immunity, and cancer: lessons from hepatitis B. Am. J. Pathol. 156:1118-1132.
22. Chitturi, S., and G. C. Farrell. 2001. Etiopathogenesis of nonalcoholic steatohepatitis. Semin. Liver Dis. 21:27-41. (Pubitemid 32240484)
23. Clippinger, A. J., and M. J. Bouchard. 2008. Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential. J. Virol. 82:6798-6811.
24. Corsetti, J., B. Way, C. Sparks, and J. Sparks. 1992. Immunolocalization, quantitation and cellular heterogeneity of apolipoprotein B in rat hepatocytes. Hepatology 15:1117-1124.
25. Cosgrove, B. D., C. Cheng, J. R. Pritchard, D. B. Stolz, D. A. Lauffenburger, and L. G. Griffith. 2008. An inducible autocrine cascade regulates rat hepatocyte proliferation and apoptosis responses to tumor necrosis factor-alpha. Hepatology 48:276-288.
26. Crabtree, G., and E. Olson. 2002. NFAT signaling: choreographing the social lives of cells. Cell 109:S67-S79.
27. Diao, J., A. A. Khine, F. Sarangi, E. Hsu, C. Iorio, L. A. Tibbles, J. R. Woodgett, J. Penninger, and C. D. Richardson. 2001. X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway. J. Biol. Chem. 276:8328-8340. (Pubitemid 37385643)
28. DiDonato, J., F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin. 1996. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16:1295-1304. (Pubitemid 26095599)
29. Diot, C., P. Gripon, M. Rissel, and C. Guguen-Guillouzo. 1992. Replication of hepatitis B virus in differentiated adult rat hepatocytes transfected with cloned viral DNA. J. Med. Virol. 36:93-100.
30. Elmore, J., A. Hancock, S.-F. Chang, X. Wang, S. Chang, C. Callahan, D. Geller, H. Will, and C. Harris. 1997. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc. Natl. Acad. Sci. USA 94:14707-14712.
31. Fausto, N., and E. M. Webber. 1994. Liver regeneration, p. 1059-1084. In I. M. Arias, J. L. Boyer, N. Fausto, W. B. Jakoby, D. A. Schachter, and D. A. Shafritz (ed.), The liver: biology and pathobiology, 3rd ed. Raven, New York, NY.
32. Gonzalez-Amaro, R., C. Garcia-Monzon, L. Garcia-Buey, R. Moreno-Otero, J. Alonso, E. Yague, J. Pivel, M. Lopez-Cabrera, E. Fernandez-Ruiz, and F. Sanchez-Madrid. 1994. Induction of tumor necrosis factor α production by human hepatocytes in chronic viral hepatitis. J. Exp. Med. 179:841-848.
33. Gottlob, K., M. Fulco, M. Levrero, and A. Graessmann. 1998. The hepatitis B virus HBx protein inhibits caspase 3 activity. J. Biol. Chem. 273:33347-33353. (Pubitemid 29005712)
34. Grossmann, M., L. A. O'Reilly, R. Gugasyan, A. Strasser, J. M. Adams, and S. Gerondakis. 2000. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J. 19:6351-6360.
35. Huang, J., J. Kwong, E. Sun, and T. Liang. 1996. Proteosome complex as a potential cellular target of hepatitis B virus X protein. J. Virol. 70:5582-5591. (Pubitemid 26240735)
36. James, S. J., I. P. Pogribny, M. Pogribna, B. J. Miller, S. Jernigan, and S. Melnyk. 2003. Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis. J. Nutr. 133:3740S-3747S.
37. Keasler, V. V., A. J. Hodgson, C. R. Madden, and B. L. Slagle. 2007. Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J. Virol. 81:2656-2662. (Pubitemid 46447031)
38. Kim, K. H., and B. L. Seong. 2003. Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal. EMBO J. 22:2104-2116. (Pubitemid 36565535)
39. Knudson, C., and N. Brown. 2008. Mitochondria potential, bax "activation," and programmed cell death. Methods Mol. Biol. 414:95-108.
40. Koike, K., K. Moriya, H. Yotsuyanagi, Y. Shintani, H. Fujie, T. Tsutsumi, and S. Kimura. 1998. Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesis. Cancer Lett. 134: 181-186. (Pubitemid 29070736)
41. Kreuz, S., D. Siegmund, P. Scheurich, and H. Wajant. 2001. NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol. Cell. Biol. 21:3964-3973.
42. t transactivator utilizes AP-1 and other transcription factors for transactivation. Hepatology 19:23-31.
43. Lee, H. H., H. Dadgostar, Q. Cheng, J. Shu, and G. Cheng. 1999. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA 96:9136-9141.
44. Lee, S., C. Tarn, W. H. Wang, S. Chen, R. L. Hullinger, and O. M. Andrisani. 2002. Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines. J. Biol. Chem. 277:8730-8740.
45. Lee, T.-H., J. Finegold, R. Shen, L. DeMayo, S. Woo, and J. Butel. 1990. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J. Virol. 64:5939-5947.
46. Lee, Y. I., J. M. Hwang, J. H. Im, N. S. Kim, D. G. Kim, D. Y. Yu, H. B. Moon, and S. K. Park. 2004. Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. J. Biol. Chem. 279:15460-15471. (Pubitemid 38618946)
47. Lee, Y. I., S. Kang-Park, S.-I. Do, and Y. I. Lee. 2001. The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J. Biol. Chem. 276:16969-16977. (Pubitemid 37411494)
48. Lindros, K. O., T. Oinonen, J. Issakainen, P. Nagy, and S. S. Thorgeirsso. 1997. Zonal distribution of transcripts of four hepatic transcription factors in the mature rat liver. Cell Biol. Toxicol. 13:257-262. (Pubitemid 27373396)
49. Locaputo, S., T. Carrick, and J. Bezerra. 1999. Zonal regulation of gene expression during liver regeneration of urokinase transgenic mice. Hepatology 29:1106-1113.
50. Lucito, R., and R. Schneider. 1992. Hepatitis B virus X protein activates transcription factor NF-κB without a requirement for protein kinase C. J. Virol. 66:983-991.
51. Madden, C. R., M. J. Finegold, and B. L. Slagle. 2000. Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice. J. Virol. 74:5266-5272. (Pubitemid 30313868)
52. Maeda, S., H. Kamata, J. L. Luo, H. Leffert, and M. Karin. 2005. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121:977-990.
53. Mahe, Y., N. Mukaida, K. Kuno, M. Akiyama, N. Ikeda, K. Matsushima, and S. Murakami. 1991. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor κB and CCAAT/enhancer-binding protein-like cis-elements. J. Biol. Chem. 266:13759-13763. (Pubitemid 21907416)
54. Marusawa, H., S. Matsuzawa, K. Welsh, H. Zou, R. Armstrong, I. Tamm, and J. C. Reed. 2003. HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J. 22:2729-2740.
55. McClain, S., A. Clippinger, R. Lizzano, and M. Bouchard. 2007. Hepatitis B virus replication is associated with an HBx-dependent mitochondrion-regulated increase in cytosolic calcium levels. J. Virol. 81:12061-12065. (Pubitemid 47623836)
56. Melegari, M., P.-P. Scaglioni, and J. R. Wands. 1998. Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J. Virol. 72:1737-1743. (Pubitemid 28100722)
57. Miao, J., G. G. Chen, S. Y. Chun, and P. P. Lai. 2006. Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression. Cancer Lett. 236:115-124.
58. Micheau, O., S. Lens, O. Gaide, K. Alevizopoulos, and J. Tschopp. 2001. NF-κB signals induce the expression of c-FLIP. Mol. Cell. Biol. 21:5299-5305. (Pubitemid 32702435)
59. Moens, U., M. Van Ghelue, and M. Johannessen. 2007. Oncogenic potentials of the human polyomavirus regulatory proteins. Cell. Mol. Life Sci. 64:1656-1678. (Pubitemid 47036940)
60. Motoyama, S., C. A. Ladines-Llave, L. Villanueva, and T. Maruo. 2004. The role of human papilloma virus in the molecular biology of cervical carcinogenesis. Kobe J. Med. Sci. 50:9-19. (Pubitemid 40136931)
61. Nuñez, G., M. Benedict, Y. Hu, and N. Inohara. 1998. Caspases: the proteases of the apoptotic pathway. Oncogene 17:3237-3245.
62. Orrenius, S., B. Zhivotovsky, and P. Nicotera. 2003. Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 4:552-565.
63. Pan, J., L. X. Duan, B. S. Sun, and M. A. Feitelson. 2001. Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa B. J. Gen. Virol. 82:171-182. (Pubitemid 32045807)
64. Paterlini, P., K. Poussin, M. Kew, D. Franco, and C. Brechot. 1995. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 21: 313-321.
65. Piechocki, M. P., R. D. Burk, and R. J. Ruch. 1999. Regulation of connexin32 and connexin43 gene expression by DNA methylation in rat liver cells. Carcinogenesis 20:401-406.
66. Pikarsky, E., R. M. Porat, I. Stein, K. Abramovitch, S. Amit, S. Kasem, E. Gutkovich-Pyest, S. Urieli-Shoval, E. Galun, and Y. Ben-Neriah. 2004. NF-κB functions as a tumor promoter in inflammation-associated cancer. Nature 431:461-466.
67. Rahmani, Z., K.-W. Huh, R. Lasher, and A. Siddiqui. 2000. Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J. Virol. 74:2840-2846.
68. Rahmani, Z., C. Maunoury, and A. Siddiqui. 1998. Isolation of a novel human voltage-dependent anion channel gene. Eur. J. Hum. Genet. 6:337-340. (Pubitemid 28395794)
69. Rodriguez-Garay, E. A. 2003. Cholestasis: human disease and experimental animal models. Ann. Hepatol. 2:150-158.
70. Runge, D., D. M. Runge, D. Jager, K. A. Lubecki, D. Beer Stolz, S. Karathanasis, T. Kietzmann, S. C. Strom, K. Jungermann, W. E. Fleig, and G. K. Michalopoulos. 2000. Serum-free, long-term cultures of human hepatocytes: maintenance of cell morphology, transcription factors, and liver-specific functions. Biochem. Biophys. Res. Commun. 269:46-53.
71. Scaglioni, P., M. Melegari, and J. Wands. 1997. Biological properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame. Virology 233:374-381.
72. Scaglioni, P., M. Melegari, and J. Wands. 1997. Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J. Virol. 71:345-353. (Pubitemid 26412298)
73. Seeger, C., F. Zoulim, and W. Mason. 2007. Hepadnaviruses, p. 2977-3029. In D. M. Knipe and P. M. Howley (ed.), Fields virology, vol.2. Lippincott Williams & Wilkins, Philadelphia, PA.
74. Seglen, P. 1993. Isolation of hepatocytes by collagenase perfusion. Methods Toxicol. 1:231-243.
75. Shih, W.-L., M.-L. Kuo, S.-E. Chuang, A.-L. Cheng, and S.-L. Doong. 2000. Hepatitis B virus X protein inhibits transforming growth factor-β-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 275:25858-25864. (Pubitemid 30658844)
76. Shinagawa, T., K. Yoshioka, S. Kakumu, T. Wakita, T. Ishikawa, Y. Itoh, and M. Takayanagi. 1991. Apoptosis in cultured rat hepatocytes: the effects of tumour necrosis factor alpha and interferon gamma. J. Pathol. 165:247-253.
77. Shintani, Y., H. Yotsuyanagi, K. Moriya, H. Fujie, T. Tsutsumi, Y. Kanegae, S. Kimura, I. Saito, and K. Koike. 1999. Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system. J. Gen. Virol. 80:3257-3265.
78. Shirakata, Y., and K. Koike. 2003. Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential. J. Biol. Chem. 278:22071-22078. (Pubitemid 36792617)
79. Su, F., and R. Schneider. 1996. Hepatitis B virus HBx protein activates transcription factor NF-κB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J. Virol. 70:4558-4566. (Pubitemid 26191145)
80. Su, F., and R. Schneider. 1997. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor α. Proc. Natl. Acad. Sci. USA 94:8744-8749.
81. Su, F., C. Theodosis, and R. Schneider. 2001. Role of NF-κB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J. Virol. 75:215-225.
82. Tai, D., S. Tsai, Y. Chang, S. Huang, T. Chen, K. Chang, and Y. Liaw. 2000. Constitutive activation of nuclear factor-kappaB in hepatocellular carcinoma. Cancer 89:2274-2281.
83. Takada, S., Y. Shirakata, N. Kaneniwa, and K. Koike. 1999. Association of hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading to cell death. Oncogene 18:6965-6973. (Pubitemid 30028865)
84. Tamatani, M., Y. H. Che, H. Matsuzaki, S. Ogawa, H. Okado, S. Miyake, T. Mizuno, and M. Tohyama. 1999. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274:8531-8538. (Pubitemid 29164643)
85. Tarn, C., S. Lee, Y. Hu, C. Ashendel, and O. M. Andrisani. 2001. Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes. J. Biol. Chem. 276:34671-34680. (Pubitemid 33662465)
86. Tarn, C., L. Zou, R. Hullinger, and O. Andrisani. 2002. Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes. J. Virol. 76:9763-9772.
87. Terradillos, O., A. de La Coste, T. Pollicino, C. Neuveut, D. Sitterlin, H. Lecoeur, M. L. Gougeon, A. Kahn, and M. A. Buendia. 2002. The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver. Oncogene 21:377-386.
88. Terradillos, O., T. Pollicino, H. Lecoeur, M. Tripodi, M. L. Gougeon, P. Tiollais, and M. A. Buendia. 1998. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 17:2115-2123. (Pubitemid 28499338)
89. Traenckner, E., H. Pahl, T. Henkel, K. Schmidt, S. Wilk, and P. Baeuerle. 1995. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14:2876-2883.
90. Wang, W. H., G. Gregori, R. L. Hullinger, and O. M. Andrisani. 2004. Sustained activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and tumor necrosis factor (TNF) receptor 1/TNF-α expression. Mol. Cell. Biol. 24:10352-10365.
91. Waris, G., K.-W. Huh, and A. Siddiqui. 2001. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-κB via oxidative stress. Mol. Cell. Biol. 21:7721-7730. (Pubitemid 32988782)
92. Weil, R., H. Sirma, C. Giannini, D. Kremsdorf, C. Bessis, C. Dargemont, C. Bréchot, and A. Israël. 1999. Direct association and nuclear import of the hepatitis B virus X protein with the NF-κB inhibitor IκBα. Mol. Cell. Biol. 19:6345-6354. (Pubitemid 29399339)
93. Wollersheim, M., U. Debelka, and P. Hofschneider. 1988. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene 3:545-552.
94. Yoshimura, K., M. Rosenfeld, P. Seth, and R. Crystal. 1993. Adenovirus-mediated augmentation of cell transfection with unmodified plasmid vectors. J. Biol. Chem. 268:2300-2303. (Pubitemid 23057841)
95. Yun, C., H.-R. Um, Y. Jin, J.-H. Wang, M.-O. Lee, S. Park, J.-H. Lee, and C. Hyeseong. 2002. NF-κB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival. Cancer Lett. 184:97-104. (Pubitemid 34718111)
96. Zoulim, F., J. Saputelli, and C. Seeger. 1994. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol. 68:2026-2030. (Pubitemid 24065779)